View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Deals Analysis
April 30, 2022

Europe’s medical devices industry saw a rise of 7.89% in deal activity during March 2022

By Carmen

Europe’s medical devices industry saw a rise of 7.89% in deal activity during March 2022, when compared with the last 12-month average, led by Angelus Sano Fund, Segulah Medical Acceleration and Waha Capital’s $49m private equity deal with Signifier Medical Technology, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

A total of 41 medical devices industry deals worth $251m were announced for the region in March 2022, against the 12-month average of 38 deals.

Of all the deal types, venture financing saw most activity in March 2022 with 20 transactions, representing a 48.8% share for the region.

In second place was M&A with 16 deals, followed by private equity deals with five transactions, respectively capturing a 39.02% and 12.2% share of the overall deal activity for the month.

In terms of value of deals, private equity was the leading category in Europe’s medical devices industry with $106.62m, while venture financing and M&A deals totalled $84.87m and $59.5m, respectively.

Europe medical devices industry deals in March 2022: Top deals

The top five medical devices deals accounted for 60.9% of the overall value during March 2022.

The combined value of the top five medical devices deals stood at $152.92m, against the overall value of $251m recorded for the month.

The top five medical devices industry deals of March 2022 tracked by GlobalData were:

1) Angelus Sano Fund,Segulah Medical Acceleration and Waha Capital $49m private equity deal with Signifier Medical Technology

2) The $36.42m private equity of ITM Isotopen Technologien Munchen by Indigenous Critical Infrastructure Fund Canada (ICIF) and Portland Investment Counsel

3) SourceBio International $24.35m acquisition deal with LDPath

4) The $21.94m acquisition of BioClue and BioStrand by BioKey and ImmunoPrecise Netherlands

5) Heights Capital Ireland $21.2m private equity deal with Renalytix AI

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU